IPX | Ticker Profile - Titan Protect

IPX

IperionX Limited

Basic Materials · Other Industrial Metals & Mining · NCM

$35.22

Data: 2026-05-28

✗ ETHICAL FAIL

Unknown MOAT

MODERATE

Data Confidence: 71.4%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.3B

Total market value of the company

Trailing P/E

N/A

Forward P/E

-79.72

Based on estimated future earnings — lower means cheaper

Rev Growth

N/A

Year-over-year revenue change

Profit Margin

0.0%

How much profit the company keeps from each dollar of revenue

ROE

-50.4%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$53.00

+50% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 5 analysts covering this stock

About IperionX Limited

IperionX Limited engages in the development of its mineral properties in the United States. It holds a 100% interest in the critical minerals Titan project, which has resources of titanium, zircon, and rare earth mineral resources in Tennessee, the United States. The company also engages in the production of angular and spherical titanium metal powders. It serves automotive and transport, consumer electronics, aerospace and defense, energy, medical, luxury goods, and industrial markets. The company was formerly known as Hyperion Metals Limited and changed its name to IperionX Limited in February 2022. IperionX Limited was incorporated in 2017 and is headquartered in Charlotte, North Carolina.

https://iperionx.com

Country: United States Industry: Other Industrial Metals & Mining

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% N/A

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

1.007

Excellent risk-adjusted returns

Kelly Fraction

0.0665

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

0.921

Acceptable balance between returns and drawdown risk

Annual Return

60.7%

Historical annualised return based on price data

Max Drawdown

-65.9%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.26

Moves slightly more than the broader market

52W High

$61.45

43% below the year high

52W Low

$21.66

63% above the year low

Avg Volume

298,254

Average daily shares traded — higher means easier to buy and sell

Short Ratio

2.4

Days it would take all short sellers to cover — higher means more crowded

Short % Float

2.3%

Low short interest — limited bearish positioning

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-2.13

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

4.12

Heavy leverage — higher financial risk if revenues decline

Current Ratio

4.03

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

3.88

Like current ratio but excludes inventory — stricter test

Gross Margin

0.0%

Revenue left after cost of goods — higher means pricing power

Operating Margin

0.0%

Profit from core operations before interest and tax

Free Cash Flow

$-46,281,996

Negative — the business is spending more than it generates

Revenue (TTM)

N/A

Total revenue over the last 12 months

Net Income

$-53,879,920

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$71.00

Target Median

$53.00

Target Low

$40.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go